Lacosamide use in refractory idiopathic primary generalized epilepsy

Area of Science:

• Neurology
• Epileptology
• Pharmacology

Background:

• Idiopathic primary generalized epilepsy (IPGE) presents treatment challenges, particularly for women of childbearing age.
• Limited antiepileptic drug options exist for refractory cases of IPGE.
• Young women with refractory epilepsy face significant therapeutic hurdles.

Observation:

• Two young women with refractory IPGE were treated with adjunctive lacosamide (LCS).
• Both patients had failed multiple monotherapy and combination antiepileptic drug treatments.
• Adjunctive LCS treatment led to long-term remission in both cases.

Findings:

• Lacosamide (LCS) demonstrated effectiveness as an adjunctive therapy in refractory idiopathic primary generalized epilepsy.
• Successful long-term remission was achieved in two young women previously unresponsive to other treatments.
• Case study suggests potential of LCS in a challenging patient population.

Implications:

• Lacosamide (LCS) may be a viable treatment option for refractory IPGE in young women.
• Further research, including larger randomized trials, is warranted to confirm LCS efficacy.
• Findings highlight the need for novel therapeutic strategies in epilepsy management.